Narrow search
Showing 1 - 6 of 6
Cover Image
The economic costs of Group B Streptococcus (GBS) disease : prospective cohort study of infants with GBS disease in England
Schroeder, Elizabeth-Ann; Petrou, Stavros; Balfour, Gail; … - In: The European journal of health economics : HEPAC ; … 10 (2009) 3, pp. 275-285
Persistent link: https://www.econbiz.de/10003857069
Cover Image
Economic evaluation of human papillomavirus screening in Germany
Mittendorf, Thomas; Petry, K. U.; Iftner, T.; Greiner, W.; … - In: The European journal of health economics : HEPAC ; … 4 (2003) 3, pp. 209-215
Persistent link: https://www.econbiz.de/10001798117
Cover Image
Economic evaluation of meningococcal vaccines : considerations for the future
Christensen, Hannah; Al-Janabi, Hareth; Lévy, Pierre; … - In: The European journal of health economics : HEPAC ; … 21 (2020) 2, pp. 297-309
Persistent link: https://www.econbiz.de/10012221975
Cover Image
Health state utilities associated with post-surgical Staphylococcus aureus infections
Matza, Louis S.; Kim, Katherine J.; Yu, Holly; Belden, … - In: The European journal of health economics : HEPAC ; … 20 (2019) 6, pp. 819-827
Persistent link: https://www.econbiz.de/10012061291
Cover Image
Costs and benefits of interventions aimed at major infectious disease threats : lessons from the literature
Kellerborg, Klas; Brouwer, Werner B. F.; Baal, Pieter van - In: The European journal of health economics : HEPAC ; … 21 (2020) 9, pp. 1329-1350
Persistent link: https://www.econbiz.de/10012491063
Cover Image
Immigrant screening for latent tuberculosis in Norway : a cost-effectiveness analysis
Haukaas, Fredrik Salvesen; Arnesen, Trude Margrete; … - In: The European journal of health economics : HEPAC ; … 18 (2017) 4, pp. 405-415
Persistent link: https://www.econbiz.de/10011868645